Global Basal Insulin (Long-Acting Insulin) Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030

Description

According to our (Global Info Research) latest study, the global Basal Insulin (Long-Acting Insulin) market size was valued at USD million in 2023 and is forecast to a readjusted size of USD million by 2030 with a CAGR of % during review period.

Long-acting insulins are also called basal or background insulins. The role of basal insulin, also known as background insulin, is to keep blood glucose levels at consistent levels during periods of fasting. When fasting , the body steadily releases glucose into the blood to our cells supplied with energy.

The Global Info Research report includes an overview of the development of the Basal Insulin (Long-Acting Insulin) industry chain, the market status of Type 1 Diabetes (Lantus, Levemir), Type 2 Diabetes (Lantus, Levemir), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Basal Insulin (Long-Acting Insulin).

Regionally, the report analyzes the Basal Insulin (Long-Acting Insulin) markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Basal Insulin (Long-Acting Insulin) market, with robust domestic demand, supportive policies, and a strong manufacturing base.

Key Features:
The report presents comprehensive understanding of the Basal Insulin (Long-Acting Insulin) market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Basal Insulin (Long-Acting Insulin) industry.

The report involves analyzing the market at a macro level:
Market Sizing and Segmentation: Report collect data on the overall market size, including the sales quantity (K Units), revenue generated, and market share of different by Type (e.g., Lantus, Levemir).

Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Basal Insulin (Long-Acting Insulin) market.

Regional Analysis: The report involves examining the Basal Insulin (Long-Acting Insulin) market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.

Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Basal Insulin (Long-Acting Insulin) market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.

The report also involves a more granular approach to Basal Insulin (Long-Acting Insulin):
Company Analysis: Report covers individual Basal Insulin (Long-Acting Insulin) manufacturers, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.

Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Basal Insulin (Long-Acting Insulin) This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Type 1 Diabetes, Type 2 Diabetes).

Technology Analysis: Report covers specific technologies relevant to Basal Insulin (Long-Acting Insulin). It assesses the current state, advancements, and potential future developments in Basal Insulin (Long-Acting Insulin) areas.

Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Basal Insulin (Long-Acting Insulin) market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.

Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.

Market Segmentation
Basal Insulin (Long-Acting Insulin) market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.

Market segment by Type
    Lantus
    Levemir
    Tresiba
    Toujeo
    Basaglar
    Biosimilar Glargines

Market segment by Application
    Type 1 Diabetes
    Type 2 Diabetes

Major players covered
    Novo Nordisk
    Sanofi Aventis
    Eli Lilly
    Biocon
    Julphar
    Exir
    Sedico
    Wockhardt

Market segment by region, regional analysis covers
    North America (United States, Canada and Mexico)
    Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
    Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
    South America (Brazil, Argentina, Colombia, and Rest of South America)
    Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)

The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Basal Insulin (Long-Acting Insulin) product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Basal Insulin (Long-Acting Insulin), with price, sales, revenue and global market share of Basal Insulin (Long-Acting Insulin) from 2019 to 2024.
Chapter 3, the Basal Insulin (Long-Acting Insulin) competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Basal Insulin (Long-Acting Insulin) breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2019 to 2030.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2019 to 2030.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2023.and Basal Insulin (Long-Acting Insulin) market forecast, by regions, type and application, with sales and revenue, from 2025 to 2030.
Chapter 12, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Basal Insulin (Long-Acting Insulin).
Chapter 14 and 15, to describe Basal Insulin (Long-Acting Insulin) sales channel, distributors, customers, research findings and conclusion.

Table of Contents

1 Market Overview
    1.1 Product Overview and Scope of Basal Insulin (Long-Acting Insulin)
    1.2 Market Estimation Caveats and Base Year
    1.3 Market Analysis by Type
        1.3.1 Overview: Global Basal Insulin (Long-Acting Insulin) Consumption Value by Type: 2019 Versus 2023 Versus 2030
        1.3.2 Lantus
        1.3.3 Levemir
        1.3.4 Tresiba
        1.3.5 Toujeo
        1.3.6 Basaglar
        1.3.7 Biosimilar Glargines
    1.4 Market Analysis by Application
        1.4.1 Overview: Global Basal Insulin (Long-Acting Insulin) Consumption Value by Application: 2019 Versus 2023 Versus 2030
        1.4.2 Type 1 Diabetes
        1.4.3 Type 2 Diabetes
    1.5 Global Basal Insulin (Long-Acting Insulin) Market Size & Forecast
        1.5.1 Global Basal Insulin (Long-Acting Insulin) Consumption Value (2019 & 2023 & 2030)
        1.5.2 Global Basal Insulin (Long-Acting Insulin) Sales Quantity (2019-2030)
        1.5.3 Global Basal Insulin (Long-Acting Insulin) Average Price (2019-2030)

2 Manufacturers Profiles
    2.1 Novo Nordisk
        2.1.1 Novo Nordisk Details
        2.1.2 Novo Nordisk Major Business
        2.1.3 Novo Nordisk Basal Insulin (Long-Acting Insulin) Product and Services
        2.1.4 Novo Nordisk Basal Insulin (Long-Acting Insulin) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
        2.1.5 Novo Nordisk Recent Developments/Updates
    2.2 Sanofi Aventis
        2.2.1 Sanofi Aventis Details
        2.2.2 Sanofi Aventis Major Business
        2.2.3 Sanofi Aventis Basal Insulin (Long-Acting Insulin) Product and Services
        2.2.4 Sanofi Aventis Basal Insulin (Long-Acting Insulin) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
        2.2.5 Sanofi Aventis Recent Developments/Updates
    2.3 Eli Lilly
        2.3.1 Eli Lilly Details
        2.3.2 Eli Lilly Major Business
        2.3.3 Eli Lilly Basal Insulin (Long-Acting Insulin) Product and Services
        2.3.4 Eli Lilly Basal Insulin (Long-Acting Insulin) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
        2.3.5 Eli Lilly Recent Developments/Updates
    2.4 Biocon
        2.4.1 Biocon Details
        2.4.2 Biocon Major Business
        2.4.3 Biocon Basal Insulin (Long-Acting Insulin) Product and Services
        2.4.4 Biocon Basal Insulin (Long-Acting Insulin) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
        2.4.5 Biocon Recent Developments/Updates
    2.5 Julphar
        2.5.1 Julphar Details
        2.5.2 Julphar Major Business
        2.5.3 Julphar Basal Insulin (Long-Acting Insulin) Product and Services
        2.5.4 Julphar Basal Insulin (Long-Acting Insulin) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
        2.5.5 Julphar Recent Developments/Updates
    2.6 Exir
        2.6.1 Exir Details
        2.6.2 Exir Major Business
        2.6.3 Exir Basal Insulin (Long-Acting Insulin) Product and Services
        2.6.4 Exir Basal Insulin (Long-Acting Insulin) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
        2.6.5 Exir Recent Developments/Updates
    2.7 Sedico
        2.7.1 Sedico Details
        2.7.2 Sedico Major Business
        2.7.3 Sedico Basal Insulin (Long-Acting Insulin) Product and Services
        2.7.4 Sedico Basal Insulin (Long-Acting Insulin) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
        2.7.5 Sedico Recent Developments/Updates
    2.8 Wockhardt
        2.8.1 Wockhardt Details
        2.8.2 Wockhardt Major Business
        2.8.3 Wockhardt Basal Insulin (Long-Acting Insulin) Product and Services
        2.8.4 Wockhardt Basal Insulin (Long-Acting Insulin) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
        2.8.5 Wockhardt Recent Developments/Updates

3 Competitive Environment: Basal Insulin (Long-Acting Insulin) by Manufacturer
    3.1 Global Basal Insulin (Long-Acting Insulin) Sales Quantity by Manufacturer (2019-2024)
    3.2 Global Basal Insulin (Long-Acting Insulin) Revenue by Manufacturer (2019-2024)
    3.3 Global Basal Insulin (Long-Acting Insulin) Average Price by Manufacturer (2019-2024)
    3.4 Market Share Analysis (2023)
        3.4.1 Producer Shipments of Basal Insulin (Long-Acting Insulin) by Manufacturer Revenue ($MM) and Market Share (%): 2023
        3.4.2 Top 3 Basal Insulin (Long-Acting Insulin) Manufacturer Market Share in 2023
        3.4.2 Top 6 Basal Insulin (Long-Acting Insulin) Manufacturer Market Share in 2023
    3.5 Basal Insulin (Long-Acting Insulin) Market: Overall Company Footprint Analysis
        3.5.1 Basal Insulin (Long-Acting Insulin) Market: Region Footprint
        3.5.2 Basal Insulin (Long-Acting Insulin) Market: Company Product Type Footprint
        3.5.3 Basal Insulin (Long-Acting Insulin) Market: Company Product Application Footprint
    3.6 New Market Entrants and Barriers to Market Entry
    3.7 Mergers, Acquisition, Agreements, and Collaborations

4 Consumption Analysis by Region
    4.1 Global Basal Insulin (Long-Acting Insulin) Market Size by Region
        4.1.1 Global Basal Insulin (Long-Acting Insulin) Sales Quantity by Region (2019-2030)
        4.1.2 Global Basal Insulin (Long-Acting Insulin) Consumption Value by Region (2019-2030)
        4.1.3 Global Basal Insulin (Long-Acting Insulin) Average Price by Region (2019-2030)
    4.2 North America Basal Insulin (Long-Acting Insulin) Consumption Value (2019-2030)
    4.3 Europe Basal Insulin (Long-Acting Insulin) Consumption Value (2019-2030)
    4.4 Asia-Pacific Basal Insulin (Long-Acting Insulin) Consumption Value (2019-2030)
    4.5 South America Basal Insulin (Long-Acting Insulin) Consumption Value (2019-2030)
    4.6 Middle East and Africa Basal Insulin (Long-Acting Insulin) Consumption Value (2019-2030)

5 Market Segment by Type
    5.1 Global Basal Insulin (Long-Acting Insulin) Sales Quantity by Type (2019-2030)
    5.2 Global Basal Insulin (Long-Acting Insulin) Consumption Value by Type (2019-2030)
    5.3 Global Basal Insulin (Long-Acting Insulin) Average Price by Type (2019-2030)

6 Market Segment by Application
    6.1 Global Basal Insulin (Long-Acting Insulin) Sales Quantity by Application (2019-2030)
    6.2 Global Basal Insulin (Long-Acting Insulin) Consumption Value by Application (2019-2030)
    6.3 Global Basal Insulin (Long-Acting Insulin) Average Price by Application (2019-2030)

7 North America
    7.1 North America Basal Insulin (Long-Acting Insulin) Sales Quantity by Type (2019-2030)
    7.2 North America Basal Insulin (Long-Acting Insulin) Sales Quantity by Application (2019-2030)
    7.3 North America Basal Insulin (Long-Acting Insulin) Market Size by Country
        7.3.1 North America Basal Insulin (Long-Acting Insulin) Sales Quantity by Country (2019-2030)
        7.3.2 North America Basal Insulin (Long-Acting Insulin) Consumption Value by Country (2019-2030)
        7.3.3 United States Market Size and Forecast (2019-2030)
        7.3.4 Canada Market Size and Forecast (2019-2030)
        7.3.5 Mexico Market Size and Forecast (2019-2030)

8 Europe
    8.1 Europe Basal Insulin (Long-Acting Insulin) Sales Quantity by Type (2019-2030)
    8.2 Europe Basal Insulin (Long-Acting Insulin) Sales Quantity by Application (2019-2030)
    8.3 Europe Basal Insulin (Long-Acting Insulin) Market Size by Country
        8.3.1 Europe Basal Insulin (Long-Acting Insulin) Sales Quantity by Country (2019-2030)
        8.3.2 Europe Basal Insulin (Long-Acting Insulin) Consumption Value by Country (2019-2030)
        8.3.3 Germany Market Size and Forecast (2019-2030)
        8.3.4 France Market Size and Forecast (2019-2030)
        8.3.5 United Kingdom Market Size and Forecast (2019-2030)
        8.3.6 Russia Market Size and Forecast (2019-2030)
        8.3.7 Italy Market Size and Forecast (2019-2030)

9 Asia-Pacific
    9.1 Asia-Pacific Basal Insulin (Long-Acting Insulin) Sales Quantity by Type (2019-2030)
    9.2 Asia-Pacific Basal Insulin (Long-Acting Insulin) Sales Quantity by Application (2019-2030)
    9.3 Asia-Pacific Basal Insulin (Long-Acting Insulin) Market Size by Region
        9.3.1 Asia-Pacific Basal Insulin (Long-Acting Insulin) Sales Quantity by Region (2019-2030)
        9.3.2 Asia-Pacific Basal Insulin (Long-Acting Insulin) Consumption Value by Region (2019-2030)
        9.3.3 China Market Size and Forecast (2019-2030)
        9.3.4 Japan Market Size and Forecast (2019-2030)
        9.3.5 Korea Market Size and Forecast (2019-2030)
        9.3.6 India Market Size and Forecast (2019-2030)
        9.3.7 Southeast Asia Market Size and Forecast (2019-2030)
        9.3.8 Australia Market Size and Forecast (2019-2030)

10 South America
    10.1 South America Basal Insulin (Long-Acting Insulin) Sales Quantity by Type (2019-2030)
    10.2 South America Basal Insulin (Long-Acting Insulin) Sales Quantity by Application (2019-2030)
    10.3 South America Basal Insulin (Long-Acting Insulin) Market Size by Country
        10.3.1 South America Basal Insulin (Long-Acting Insulin) Sales Quantity by Country (2019-2030)
        10.3.2 South America Basal Insulin (Long-Acting Insulin) Consumption Value by Country (2019-2030)
        10.3.3 Brazil Market Size and Forecast (2019-2030)
        10.3.4 Argentina Market Size and Forecast (2019-2030)

11 Middle East & Africa
    11.1 Middle East & Africa Basal Insulin (Long-Acting Insulin) Sales Quantity by Type (2019-2030)
    11.2 Middle East & Africa Basal Insulin (Long-Acting Insulin) Sales Quantity by Application (2019-2030)
    11.3 Middle East & Africa Basal Insulin (Long-Acting Insulin) Market Size by Country
        11.3.1 Middle East & Africa Basal Insulin (Long-Acting Insulin) Sales Quantity by Country (2019-2030)
        11.3.2 Middle East & Africa Basal Insulin (Long-Acting Insulin) Consumption Value by Country (2019-2030)
        11.3.3 Turkey Market Size and Forecast (2019-2030)
        11.3.4 Egypt Market Size and Forecast (2019-2030)
        11.3.5 Saudi Arabia Market Size and Forecast (2019-2030)
        11.3.6 South Africa Market Size and Forecast (2019-2030)

12 Market Dynamics
    12.1 Basal Insulin (Long-Acting Insulin) Market Drivers
    12.2 Basal Insulin (Long-Acting Insulin) Market Restraints
    12.3 Basal Insulin (Long-Acting Insulin) Trends Analysis
    12.4 Porters Five Forces Analysis
        12.4.1 Threat of New Entrants
        12.4.2 Bargaining Power of Suppliers
        12.4.3 Bargaining Power of Buyers
        12.4.4 Threat of Substitutes
        12.4.5 Competitive Rivalry

13 Raw Material and Industry Chain
    13.1 Raw Material of Basal Insulin (Long-Acting Insulin) and Key Manufacturers
    13.2 Manufacturing Costs Percentage of Basal Insulin (Long-Acting Insulin)
    13.3 Basal Insulin (Long-Acting Insulin) Production Process
    13.4 Basal Insulin (Long-Acting Insulin) Industrial Chain

14 Shipments by Distribution Channel
    14.1 Sales Channel
        14.1.1 Direct to End-User
        14.1.2 Distributors
    14.2 Basal Insulin (Long-Acting Insulin) Typical Distributors
    14.3 Basal Insulin (Long-Acting Insulin) Typical Customers

15 Research Findings and Conclusion

16 Appendix
    16.1 Methodology
    16.2 Research Process and Data Source
    16.3 Disclaimer

Table of Figures

List of Tables
    Table 1. Global Basal Insulin (Long-Acting Insulin) Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
    Table 2. Global Basal Insulin (Long-Acting Insulin) Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
    Table 3. Novo Nordisk Basic Information, Manufacturing Base and Competitors
    Table 4. Novo Nordisk Major Business
    Table 5. Novo Nordisk Basal Insulin (Long-Acting Insulin) Product and Services
    Table 6. Novo Nordisk Basal Insulin (Long-Acting Insulin) Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 7. Novo Nordisk Recent Developments/Updates
    Table 8. Sanofi Aventis Basic Information, Manufacturing Base and Competitors
    Table 9. Sanofi Aventis Major Business
    Table 10. Sanofi Aventis Basal Insulin (Long-Acting Insulin) Product and Services
    Table 11. Sanofi Aventis Basal Insulin (Long-Acting Insulin) Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 12. Sanofi Aventis Recent Developments/Updates
    Table 13. Eli Lilly Basic Information, Manufacturing Base and Competitors
    Table 14. Eli Lilly Major Business
    Table 15. Eli Lilly Basal Insulin (Long-Acting Insulin) Product and Services
    Table 16. Eli Lilly Basal Insulin (Long-Acting Insulin) Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 17. Eli Lilly Recent Developments/Updates
    Table 18. Biocon Basic Information, Manufacturing Base and Competitors
    Table 19. Biocon Major Business
    Table 20. Biocon Basal Insulin (Long-Acting Insulin) Product and Services
    Table 21. Biocon Basal Insulin (Long-Acting Insulin) Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 22. Biocon Recent Developments/Updates
    Table 23. Julphar Basic Information, Manufacturing Base and Competitors
    Table 24. Julphar Major Business
    Table 25. Julphar Basal Insulin (Long-Acting Insulin) Product and Services
    Table 26. Julphar Basal Insulin (Long-Acting Insulin) Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 27. Julphar Recent Developments/Updates
    Table 28. Exir Basic Information, Manufacturing Base and Competitors
    Table 29. Exir Major Business
    Table 30. Exir Basal Insulin (Long-Acting Insulin) Product and Services
    Table 31. Exir Basal Insulin (Long-Acting Insulin) Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 32. Exir Recent Developments/Updates
    Table 33. Sedico Basic Information, Manufacturing Base and Competitors
    Table 34. Sedico Major Business
    Table 35. Sedico Basal Insulin (Long-Acting Insulin) Product and Services
    Table 36. Sedico Basal Insulin (Long-Acting Insulin) Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 37. Sedico Recent Developments/Updates
    Table 38. Wockhardt Basic Information, Manufacturing Base and Competitors
    Table 39. Wockhardt Major Business
    Table 40. Wockhardt Basal Insulin (Long-Acting Insulin) Product and Services
    Table 41. Wockhardt Basal Insulin (Long-Acting Insulin) Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 42. Wockhardt Recent Developments/Updates
    Table 43. Global Basal Insulin (Long-Acting Insulin) Sales Quantity by Manufacturer (2019-2024) & (K Units)
    Table 44. Global Basal Insulin (Long-Acting Insulin) Revenue by Manufacturer (2019-2024) & (USD Million)
    Table 45. Global Basal Insulin (Long-Acting Insulin) Average Price by Manufacturer (2019-2024) & (US$/Unit)
    Table 46. Market Position of Manufacturers in Basal Insulin (Long-Acting Insulin), (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2023
    Table 47. Head Office and Basal Insulin (Long-Acting Insulin) Production Site of Key Manufacturer
    Table 48. Basal Insulin (Long-Acting Insulin) Market: Company Product Type Footprint
    Table 49. Basal Insulin (Long-Acting Insulin) Market: Company Product Application Footprint
    Table 50. Basal Insulin (Long-Acting Insulin) New Market Entrants and Barriers to Market Entry
    Table 51. Basal Insulin (Long-Acting Insulin) Mergers, Acquisition, Agreements, and Collaborations
    Table 52. Global Basal Insulin (Long-Acting Insulin) Sales Quantity by Region (2019-2024) & (K Units)
    Table 53. Global Basal Insulin (Long-Acting Insulin) Sales Quantity by Region (2025-2030) & (K Units)
    Table 54. Global Basal Insulin (Long-Acting Insulin) Consumption Value by Region (2019-2024) & (USD Million)
    Table 55. Global Basal Insulin (Long-Acting Insulin) Consumption Value by Region (2025-2030) & (USD Million)
    Table 56. Global Basal Insulin (Long-Acting Insulin) Average Price by Region (2019-2024) & (US$/Unit)
    Table 57. Global Basal Insulin (Long-Acting Insulin) Average Price by Region (2025-2030) & (US$/Unit)
    Table 58. Global Basal Insulin (Long-Acting Insulin) Sales Quantity by Type (2019-2024) & (K Units)
    Table 59. Global Basal Insulin (Long-Acting Insulin) Sales Quantity by Type (2025-2030) & (K Units)
    Table 60. Global Basal Insulin (Long-Acting Insulin) Consumption Value by Type (2019-2024) & (USD Million)
    Table 61. Global Basal Insulin (Long-Acting Insulin) Consumption Value by Type (2025-2030) & (USD Million)
    Table 62. Global Basal Insulin (Long-Acting Insulin) Average Price by Type (2019-2024) & (US$/Unit)
    Table 63. Global Basal Insulin (Long-Acting Insulin) Average Price by Type (2025-2030) & (US$/Unit)
    Table 64. Global Basal Insulin (Long-Acting Insulin) Sales Quantity by Application (2019-2024) & (K Units)
    Table 65. Global Basal Insulin (Long-Acting Insulin) Sales Quantity by Application (2025-2030) & (K Units)
    Table 66. Global Basal Insulin (Long-Acting Insulin) Consumption Value by Application (2019-2024) & (USD Million)
    Table 67. Global Basal Insulin (Long-Acting Insulin) Consumption Value by Application (2025-2030) & (USD Million)
    Table 68. Global Basal Insulin (Long-Acting Insulin) Average Price by Application (2019-2024) & (US$/Unit)
    Table 69. Global Basal Insulin (Long-Acting Insulin) Average Price by Application (2025-2030) & (US$/Unit)
    Table 70. North America Basal Insulin (Long-Acting Insulin) Sales Quantity by Type (2019-2024) & (K Units)
    Table 71. North America Basal Insulin (Long-Acting Insulin) Sales Quantity by Type (2025-2030) & (K Units)
    Table 72. North America Basal Insulin (Long-Acting Insulin) Sales Quantity by Application (2019-2024) & (K Units)
    Table 73. North America Basal Insulin (Long-Acting Insulin) Sales Quantity by Application (2025-2030) & (K Units)
    Table 74. North America Basal Insulin (Long-Acting Insulin) Sales Quantity by Country (2019-2024) & (K Units)
    Table 75. North America Basal Insulin (Long-Acting Insulin) Sales Quantity by Country (2025-2030) & (K Units)
    Table 76. North America Basal Insulin (Long-Acting Insulin) Consumption Value by Country (2019-2024) & (USD Million)
    Table 77. North America Basal Insulin (Long-Acting Insulin) Consumption Value by Country (2025-2030) & (USD Million)
    Table 78. Europe Basal Insulin (Long-Acting Insulin) Sales Quantity by Type (2019-2024) & (K Units)
    Table 79. Europe Basal Insulin (Long-Acting Insulin) Sales Quantity by Type (2025-2030) & (K Units)
    Table 80. Europe Basal Insulin (Long-Acting Insulin) Sales Quantity by Application (2019-2024) & (K Units)
    Table 81. Europe Basal Insulin (Long-Acting Insulin) Sales Quantity by Application (2025-2030) & (K Units)
    Table 82. Europe Basal Insulin (Long-Acting Insulin) Sales Quantity by Country (2019-2024) & (K Units)
    Table 83. Europe Basal Insulin (Long-Acting Insulin) Sales Quantity by Country (2025-2030) & (K Units)
    Table 84. Europe Basal Insulin (Long-Acting Insulin) Consumption Value by Country (2019-2024) & (USD Million)
    Table 85. Europe Basal Insulin (Long-Acting Insulin) Consumption Value by Country (2025-2030) & (USD Million)
    Table 86. Asia-Pacific Basal Insulin (Long-Acting Insulin) Sales Quantity by Type (2019-2024) & (K Units)
    Table 87. Asia-Pacific Basal Insulin (Long-Acting Insulin) Sales Quantity by Type (2025-2030) & (K Units)
    Table 88. Asia-Pacific Basal Insulin (Long-Acting Insulin) Sales Quantity by Application (2019-2024) & (K Units)
    Table 89. Asia-Pacific Basal Insulin (Long-Acting Insulin) Sales Quantity by Application (2025-2030) & (K Units)
    Table 90. Asia-Pacific Basal Insulin (Long-Acting Insulin) Sales Quantity by Region (2019-2024) & (K Units)
    Table 91. Asia-Pacific Basal Insulin (Long-Acting Insulin) Sales Quantity by Region (2025-2030) & (K Units)
    Table 92. Asia-Pacific Basal Insulin (Long-Acting Insulin) Consumption Value by Region (2019-2024) & (USD Million)
    Table 93. Asia-Pacific Basal Insulin (Long-Acting Insulin) Consumption Value by Region (2025-2030) & (USD Million)
    Table 94. South America Basal Insulin (Long-Acting Insulin) Sales Quantity by Type (2019-2024) & (K Units)
    Table 95. South America Basal Insulin (Long-Acting Insulin) Sales Quantity by Type (2025-2030) & (K Units)
    Table 96. South America Basal Insulin (Long-Acting Insulin) Sales Quantity by Application (2019-2024) & (K Units)
    Table 97. South America Basal Insulin (Long-Acting Insulin) Sales Quantity by Application (2025-2030) & (K Units)
    Table 98. South America Basal Insulin (Long-Acting Insulin) Sales Quantity by Country (2019-2024) & (K Units)
    Table 99. South America Basal Insulin (Long-Acting Insulin) Sales Quantity by Country (2025-2030) & (K Units)
    Table 100. South America Basal Insulin (Long-Acting Insulin) Consumption Value by Country (2019-2024) & (USD Million)
    Table 101. South America Basal Insulin (Long-Acting Insulin) Consumption Value by Country (2025-2030) & (USD Million)
    Table 102. Middle East & Africa Basal Insulin (Long-Acting Insulin) Sales Quantity by Type (2019-2024) & (K Units)
    Table 103. Middle East & Africa Basal Insulin (Long-Acting Insulin) Sales Quantity by Type (2025-2030) & (K Units)
    Table 104. Middle East & Africa Basal Insulin (Long-Acting Insulin) Sales Quantity by Application (2019-2024) & (K Units)
    Table 105. Middle East & Africa Basal Insulin (Long-Acting Insulin) Sales Quantity by Application (2025-2030) & (K Units)
    Table 106. Middle East & Africa Basal Insulin (Long-Acting Insulin) Sales Quantity by Region (2019-2024) & (K Units)
    Table 107. Middle East & Africa Basal Insulin (Long-Acting Insulin) Sales Quantity by Region (2025-2030) & (K Units)
    Table 108. Middle East & Africa Basal Insulin (Long-Acting Insulin) Consumption Value by Region (2019-2024) & (USD Million)
    Table 109. Middle East & Africa Basal Insulin (Long-Acting Insulin) Consumption Value by Region (2025-2030) & (USD Million)
    Table 110. Basal Insulin (Long-Acting Insulin) Raw Material
    Table 111. Key Manufacturers of Basal Insulin (Long-Acting Insulin) Raw Materials
    Table 112. Basal Insulin (Long-Acting Insulin) Typical Distributors
    Table 113. Basal Insulin (Long-Acting Insulin) Typical Customers
List of Figures
    Figure 1. Basal Insulin (Long-Acting Insulin) Picture
    Figure 2. Global Basal Insulin (Long-Acting Insulin) Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
    Figure 3. Global Basal Insulin (Long-Acting Insulin) Consumption Value Market Share by Type in 2023
    Figure 4. Lantus Examples
    Figure 5. Levemir Examples
    Figure 6. Tresiba Examples
    Figure 7. Toujeo Examples
    Figure 8. Basaglar Examples
    Figure 9. Biosimilar Glargines Examples
    Figure 10. Global Basal Insulin (Long-Acting Insulin) Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
    Figure 11. Global Basal Insulin (Long-Acting Insulin) Consumption Value Market Share by Application in 2023
    Figure 12. Type 1 Diabetes Examples
    Figure 13. Type 2 Diabetes Examples
    Figure 14. Global Basal Insulin (Long-Acting Insulin) Consumption Value, (USD Million): 2019 & 2023 & 2030
    Figure 15. Global Basal Insulin (Long-Acting Insulin) Consumption Value and Forecast (2019-2030) & (USD Million)
    Figure 16. Global Basal Insulin (Long-Acting Insulin) Sales Quantity (2019-2030) & (K Units)
    Figure 17. Global Basal Insulin (Long-Acting Insulin) Average Price (2019-2030) & (US$/Unit)
    Figure 18. Global Basal Insulin (Long-Acting Insulin) Sales Quantity Market Share by Manufacturer in 2023
    Figure 19. Global Basal Insulin (Long-Acting Insulin) Consumption Value Market Share by Manufacturer in 2023
    Figure 20. Producer Shipments of Basal Insulin (Long-Acting Insulin) by Manufacturer Sales Quantity ($MM) and Market Share (%): 2023
    Figure 21. Top 3 Basal Insulin (Long-Acting Insulin) Manufacturer (Consumption Value) Market Share in 2023
    Figure 22. Top 6 Basal Insulin (Long-Acting Insulin) Manufacturer (Consumption Value) Market Share in 2023
    Figure 23. Global Basal Insulin (Long-Acting Insulin) Sales Quantity Market Share by Region (2019-2030)
    Figure 24. Global Basal Insulin (Long-Acting Insulin) Consumption Value Market Share by Region (2019-2030)
    Figure 25. North America Basal Insulin (Long-Acting Insulin) Consumption Value (2019-2030) & (USD Million)
    Figure 26. Europe Basal Insulin (Long-Acting Insulin) Consumption Value (2019-2030) & (USD Million)
    Figure 27. Asia-Pacific Basal Insulin (Long-Acting Insulin) Consumption Value (2019-2030) & (USD Million)
    Figure 28. South America Basal Insulin (Long-Acting Insulin) Consumption Value (2019-2030) & (USD Million)
    Figure 29. Middle East & Africa Basal Insulin (Long-Acting Insulin) Consumption Value (2019-2030) & (USD Million)
    Figure 30. Global Basal Insulin (Long-Acting Insulin) Sales Quantity Market Share by Type (2019-2030)
    Figure 31. Global Basal Insulin (Long-Acting Insulin) Consumption Value Market Share by Type (2019-2030)
    Figure 32. Global Basal Insulin (Long-Acting Insulin) Average Price by Type (2019-2030) & (US$/Unit)
    Figure 33. Global Basal Insulin (Long-Acting Insulin) Sales Quantity Market Share by Application (2019-2030)
    Figure 34. Global Basal Insulin (Long-Acting Insulin) Consumption Value Market Share by Application (2019-2030)
    Figure 35. Global Basal Insulin (Long-Acting Insulin) Average Price by Application (2019-2030) & (US$/Unit)
    Figure 36. North America Basal Insulin (Long-Acting Insulin) Sales Quantity Market Share by Type (2019-2030)
    Figure 37. North America Basal Insulin (Long-Acting Insulin) Sales Quantity Market Share by Application (2019-2030)
    Figure 38. North America Basal Insulin (Long-Acting Insulin) Sales Quantity Market Share by Country (2019-2030)
    Figure 39. North America Basal Insulin (Long-Acting Insulin) Consumption Value Market Share by Country (2019-2030)
    Figure 40. United States Basal Insulin (Long-Acting Insulin) Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 41. Canada Basal Insulin (Long-Acting Insulin) Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 42. Mexico Basal Insulin (Long-Acting Insulin) Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 43. Europe Basal Insulin (Long-Acting Insulin) Sales Quantity Market Share by Type (2019-2030)
    Figure 44. Europe Basal Insulin (Long-Acting Insulin) Sales Quantity Market Share by Application (2019-2030)
    Figure 45. Europe Basal Insulin (Long-Acting Insulin) Sales Quantity Market Share by Country (2019-2030)
    Figure 46. Europe Basal Insulin (Long-Acting Insulin) Consumption Value Market Share by Country (2019-2030)
    Figure 47. Germany Basal Insulin (Long-Acting Insulin) Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 48. France Basal Insulin (Long-Acting Insulin) Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 49. United Kingdom Basal Insulin (Long-Acting Insulin) Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 50. Russia Basal Insulin (Long-Acting Insulin) Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 51. Italy Basal Insulin (Long-Acting Insulin) Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 52. Asia-Pacific Basal Insulin (Long-Acting Insulin) Sales Quantity Market Share by Type (2019-2030)
    Figure 53. Asia-Pacific Basal Insulin (Long-Acting Insulin) Sales Quantity Market Share by Application (2019-2030)
    Figure 54. Asia-Pacific Basal Insulin (Long-Acting Insulin) Sales Quantity Market Share by Region (2019-2030)
    Figure 55. Asia-Pacific Basal Insulin (Long-Acting Insulin) Consumption Value Market Share by Region (2019-2030)
    Figure 56. China Basal Insulin (Long-Acting Insulin) Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 57. Japan Basal Insulin (Long-Acting Insulin) Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 58. Korea Basal Insulin (Long-Acting Insulin) Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 59. India Basal Insulin (Long-Acting Insulin) Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 60. Southeast Asia Basal Insulin (Long-Acting Insulin) Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 61. Australia Basal Insulin (Long-Acting Insulin) Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 62. South America Basal Insulin (Long-Acting Insulin) Sales Quantity Market Share by Type (2019-2030)
    Figure 63. South America Basal Insulin (Long-Acting Insulin) Sales Quantity Market Share by Application (2019-2030)
    Figure 64. South America Basal Insulin (Long-Acting Insulin) Sales Quantity Market Share by Country (2019-2030)
    Figure 65. South America Basal Insulin (Long-Acting Insulin) Consumption Value Market Share by Country (2019-2030)
    Figure 66. Brazil Basal Insulin (Long-Acting Insulin) Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 67. Argentina Basal Insulin (Long-Acting Insulin) Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 68. Middle East & Africa Basal Insulin (Long-Acting Insulin) Sales Quantity Market Share by Type (2019-2030)
    Figure 69. Middle East & Africa Basal Insulin (Long-Acting Insulin) Sales Quantity Market Share by Application (2019-2030)
    Figure 70. Middle East & Africa Basal Insulin (Long-Acting Insulin) Sales Quantity Market Share by Region (2019-2030)
    Figure 71. Middle East & Africa Basal Insulin (Long-Acting Insulin) Consumption Value Market Share by Region (2019-2030)
    Figure 72. Turkey Basal Insulin (Long-Acting Insulin) Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 73. Egypt Basal Insulin (Long-Acting Insulin) Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 74. Saudi Arabia Basal Insulin (Long-Acting Insulin) Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 75. South Africa Basal Insulin (Long-Acting Insulin) Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 76. Basal Insulin (Long-Acting Insulin) Market Drivers
    Figure 77. Basal Insulin (Long-Acting Insulin) Market Restraints
    Figure 78. Basal Insulin (Long-Acting Insulin) Market Trends
    Figure 79. Porters Five Forces Analysis
    Figure 80. Manufacturing Cost Structure Analysis of Basal Insulin (Long-Acting Insulin) in 2023
    Figure 81. Manufacturing Process Analysis of Basal Insulin (Long-Acting Insulin)
    Figure 82. Basal Insulin (Long-Acting Insulin) Industrial Chain
    Figure 83. Sales Quantity Channel: Direct to End-User vs Distributors
    Figure 84. Direct Channel Pros & Cons
    Figure 85. Indirect Channel Pros & Cons
    Figure 86. Methodology
    Figure 87. Research Process and Data Source

Companies Mentioned

Novo Nordisk
Sanofi Aventis
Eli Lilly
Biocon
Julphar
Exir
Sedico
Wockhardt